MCHC measures the concentration of hemoglobin inside red blood cells, essentially how "packed" each cell is with hemoglobin. Unlike MCH (which measures hemoglobin mass), MCHC accounts for cell size, giving a density-like value.
Low MCHC (hypochromia) reflects hemoglobin-poor cells and usually accompanies iron deficiency. Elevated MCHC is unusual and may indicate hereditary spherocytosis or cold agglutinin disease, or it can be a lab artifact. MCHC is most useful as a confirmation marker alongside MCV and MCH. All three dropping together tells a consistent iron-deficiency story.
Optimal MCHC: 34-36 g/dL.
Typically re-tested every 12 weeks.
MCHC is calculated rather than measured directly, which is why it is always read next to cell size, cell hemoglobin content and iron storage markers rather than on its own.
MCHC is the average concentration of hemoglobin inside a fixed volume of packed red blood cells, a measure of how densely each cell is filled rather than how much hemoglobin you carry in total.
Most analyzers derive it by dividing your hemoglobin by your hematocrit and multiplying by 100, so the result inherits the accuracy of both of those numbers. Hemoglobin is the iron-containing protein that binds oxygen in the lungs and releases it in tissue. Hematocrit is the proportion of blood volume occupied by red cells. Dividing one by the other answers a narrow question, how concentrated is the hemoglobin inside the cells you have.
That makes MCHC different from its two neighbours on the report. MCV describes average red cell size. MCH describes the average mass of hemoglobin per cell. MCHC describes density, hemoglobin per unit of cell volume. A cell can be small and still well filled, or normal in size and underfilled, and the three indices together tell you which pattern you are looking at.
Laboratory scientists use the older descriptive words for the same idea. Cells with a normal MCHC are called normochromic. Cells with a low MCHC are hypochromic, meaning they look paler under the microscope because there is less hemoglobin per unit volume. A result above the reference range is sometimes called hyperchromic, although true biological hyperchromia is uncommon and the finding is often technical instead.
Because MCHC is a ratio of two separately measured values, it also doubles as an internal quality check. An implausible result frequently signals a problem with the sample rather than with the person who gave it.
MCHC matters because it reports on the efficiency of oxygen transport at the level of the individual cell, and because a persistent drift in that number is often the earliest visible sign that iron supply, inflammation or red cell structure has changed.
Red blood cells work by being both well loaded and flexible. They have to squeeze through capillaries narrower than they are, release oxygen, and return. Hemoglobin concentration inside the cell influences how stiff or deformable the cell is, so values at either edge of the range describe cells that are either underfilled or unusually rigid. Neither state is a diagnosis on its own, but both are worth understanding over time.
The practical value of MCHC in a health optimization context is its behaviour across repeat testing. A single result sitting slightly low is weak information. The same result trending downward over several draws, alongside a falling ferritin and a rising red cell distribution width, is a much stronger pattern and one that is worth discussing with a clinician.
Work on the burden of major adverse cardiac events in coronary artery disease has drawn on routinely collected clinical and laboratory data[1], and composite ranking methods have been applied to routine variables from hospital cohorts to compare risk factors[2]. Pre-treatment blood markers have likewise been analysed as potential predictors of benefit in cancer immunotherapy research[3]. None of that makes MCHC a standalone risk score. It simply reflects how often red cell measures travel alongside broader health signals.
A typical adult laboratory reference range for MCHC is 32 to 36 g/dL, and FitScript's optimal range is 34 to 36 g/dL.
| Measure | Range | What it represents |
|---|---|---|
| Typical lab reference range | 32 to 36 g/dL | The band most adult results fall within, used by laboratories to flag results for review |
| FitScript optimal range | 34 to 36 g/dL | FitScript's optimization target for members, a narrower band within the standard range |
In 2,417 healthy adults from the ELSA-Brasil study, MCHC ran slightly higher in men than in women, and it did not differ meaningfully between people aged 35 to 59 and those 60 and over.[13]
| Sex | Age | Reference range (g/dL) |
|---|---|---|
| Men | 35 and over | 32.3 to 35.7 |
| Women | 35 and over | 32 to 35.1 |
| Men and women | 35 and over | 32 to 35.5 |
Because age made no meaningful difference in this study, one range covers every adult age group.[13]
These are typical lab reference ranges, and they vary by laboratory, analyzer, age and sex. The range printed next to your own result is the one your report was flagged against, so compare to that first. FitScript's optimal range is an optimization target, not a diagnostic cut-off, and a value outside it is not a finding of disease.
One detail often causes confusion. Hemoglobin and hematocrit ranges are usually published separately for men and women, but many laboratories publish a single adult MCHC range, because the ratio between those two values is far more stable across sexes than either number alone. Some analyzers also report MCHC in g/L rather than g/dL, which shifts the decimal point and makes a value such as 340 g/L identical to 34 g/dL.
An MCHC above the reference range means the analyzer calculated an unusually dense hemoglobin concentration inside your red cells, and in practice this is caused either by a change in cell shape or membrane, or by something about the sample itself.
Most people with a mildly raised MCHC report no symptoms at all and only see it because a full blood count was run for another reason. When a raised MCHC accompanies ongoing red cell breakdown, people more often describe fatigue that rest does not fix, breathlessness on exertion, a yellowish tint to the skin or eyes, darker urine, or discomfort under the left ribs. Those are descriptions people report, not criteria for any condition.
On causes, hereditary spherocytosis is the classic biological reason for a high MCHC, because the affected cells lose membrane surface and become small spheres with densely packed hemoglobin. Reviews of how that condition is diagnosed discuss red cell indices among the screening tools used[4]. Autoimmune destruction of red cells and severe burns can produce a similar picture. Technical causes are at least as common, including cold agglutinins clumping cells, a lipemic sample after a very high fat meal, partial breakdown of the sample in transit, or a very high white cell count interfering with the measurement. A repeat draw often resolves the question.
Over the long term, the concern attached to a genuinely raised MCHC is the consequence of ongoing cell turnover rather than the number itself, which can include gallstones, an enlarged spleen and episodic drops in hemoglobin. A result that sits outside the standard range on more than one occasion is suboptimal and worth discussing with a clinician promptly, who can decide whether further testing is warranted.
A low MCHC means your red cells are hypochromic, carrying less hemoglobin per unit of cell volume than expected, and the most frequent explanation in otherwise healthy adults is limited iron availability for making hemoglobin.
People with a low MCHC commonly describe tiredness that builds through the day, breathlessness or a racing heart with exercise that used to feel easy, cold hands and feet, headaches, poor recovery between training sessions, more hair shedding than usual, and pale skin or inner eyelids. Many people have no symptoms, particularly when the change has been gradual and the body has adapted.
Common causes cluster into a few groups. Iron deficiency comes from low intake, poor absorption or steady loss, and controlled trials have tested iron preparations for controlling iron deficiency during pregnancy, when demand rises sharply[5]. Iron deficiency is also frequently identified around surgery, where its incidence and the role of intravenous iron have been reviewed[6]. Inherited thalassemia traits produce small, pale cells lifelong without iron deficiency. Chronic inflammation can lock iron away from the bone marrow even when stores look adequate. Copper deficiency is a rarer cause of hypochromic anemia, and while very high zinc intake is often raised as a risk to copper status, one trial found that four months of zinc supplementation in infants did not affect plasma copper concentration[7]. Inflammatory bowel conditions add absorption problems, and research has examined correlations between vitamin A status and anemia in Crohn disease[8].
Left unaddressed over years, low hemoglobin density tends to show up as reduced exercise capacity, worse recovery and more strain in situations that demand oxygen delivery. In kidney care, reticulocyte hemoglobin content has been studied as a way to read iron availability in people on chronic hemodialysis[9], which illustrates how closely cell-level hemoglobin measures are tracked when supply is limited. A persistently low MCHC deserves a conversation with a clinician rather than self-managed supplementation.
MCHC can shift for reasons that have nothing to do with your underlying health, which is why one unexpected value is treated as a prompt to retest rather than a conclusion.
Testing conditions matter most for the high side. Time and temperature between the draw and the analysis, a partially hemolyzed tube, cold agglutinins, lipemia from a recent fatty meal, and differences between analyzer platforms can all nudge the calculated value. Comparing results run on different equipment at different laboratories introduces variation that is not biological. Hydration has less effect on MCHC than people expect, because dehydration concentrates hemoglobin and hematocrit roughly in step, and the ratio between them changes little even though both rise.
Medications and treatments can move red cell indices genuinely. Hematologic changes have been reported in patients with metastatic breast cancer receiving everolimus[10], and hematological indices in cancer patients receiving chemotherapy with radiotherapy or radiotherapy alone have been reviewed as a group[11]. Iron repletion, when a licensed provider has evaluated it as appropriate, typically raises hypochromic indices over weeks to months as new cells replace old ones. No dosing or schedule is given here, because that decision belongs to a licensed provider who has reviewed your results.
Habits and life stages contribute as well. Heavy menstrual bleeding, frequent blood donation, high-volume endurance training, restrictive eating patterns and pregnancy all change iron demand or loss. Pregnancy research routinely tracks blood measures alongside other exposures, including work examining arsenic concentration in peripheral blood in relation to preeclampsia[12]. Living at altitude changes red cell production more than hemoglobin density. Ageing shifts marrow output gradually, which is one reason trends read better than single values.
MCHC is measured as part of the complete blood count, which sits inside FitScript's standard lab panels rather than being ordered as a separate test, so it arrives alongside the markers needed to interpret it.
FitScript members have 150+ biomarkers tested per year, which means MCHC is not a one-off snapshot. Repeat testing turns a borderline value into a direction of travel, and direction is what makes a red cell index useful. A result of 33 g/dL that has been stable for three draws reads very differently from a result of 33 g/dL that was 35 g/dL six months ago.
Atlas, FitScript's AI health advisor, reads each result in context rather than in isolation, pairing MCHC with cell size, cell hemoglobin content, red cell distribution width, iron storage and inflammation markers, then explaining what the pattern suggests and what is worth watching. That interpretation becomes part of your FitScript, the personalized output written from your own biology, including nutrition and training adjustments that may support better iron handling.
Where a result raises a question that nutrition and habit changes cannot answer, the next step is clinical. Any prescription option, including iron therapy delivered in a clinical setting or further hematology workup, is evaluated by a licensed provider who reviews your history and your full results and decides whether it is appropriate. FitScript does not treat a number in isolation, and neither should you.
MCHC, short for mean corpuscular hemoglobin concentration, is printed with the red cell indices on the complete blood count and reported in grams per deciliter (g/dL). An H or L flag compares it with that lab's own reference interval, and it is read with MCV and MCH.
MCHC is close to meaningless alone and highly informative in a group, so read it with the rest of the red cell panel and the iron markers.
Cell size tells you whether underfilled cells are also small, which is the usual pattern in iron deficiency and thalassemia traits, or normal in size, which points elsewhere. Average hemoglobin mass per cell moves with cell size and helps separate those cases. Total hemoglobin and the proportion of blood volume made up of red cells are the two values MCHC is calculated from, so an odd MCHC always warrants a look at both. Red cell count completes the picture of how many cells the marrow is producing.
Iron storage is the single most useful companion marker, because it often falls well before the red cell indices move, making it an earlier signal than MCHC itself. Red cell distribution width adds information about how variable your cell population is, which tends to rise early when a new, differently filled generation of cells enters circulation. Inflammatory markers help explain iron that is present but unavailable, and B12 and folate cover the opposite pattern of larger cells. Reticulocyte measures show how actively the marrow is responding.
If you want to go deeper on the individual markers, see MCV, MCH, Hemoglobin, Hematocrit, RBC and Ferritin, or review what is included in FitScript Essential.
Treat MCHC as one line in a pattern. Note where it sits against your own laboratory's range, look at cell size, cell hemoglobin content and iron storage next to it, and pay more attention to the direction across repeat tests than to a single value. If the number is outside the standard range, or if it has moved meaningfully since your last draw, bring the full report rather than the one value to your clinician or licensed provider and discuss what, if anything, should be investigated. This page is educational and is not medical advice.
MCHC stands for mean corpuscular hemoglobin concentration. It is the average concentration of hemoglobin inside a fixed volume of your packed red blood cells, usually reported in g/dL. It is calculated from your hemoglobin and hematocrit rather than measured directly, so it is read alongside those two values and the other red cell indices.
A typical adult laboratory reference range is 32 to 36 g/dL, and FitScript's optimal range is 34 to 36 g/dL. Optimal ranges are optimization targets rather than diagnostic cut-offs. Reference ranges vary by laboratory, analyzer, age and sex, so compare your result against the range printed on your own report.
A single high MCHC is more often technical than biological. Cold agglutinins, a fatty sample, partial breakdown of blood in transit or a very high white cell count can all raise the calculated value. Genuine causes include red cell membrane conditions such as hereditary spherocytosis. A value outside the standard range on more than one test is worth discussing with a clinician promptly.
Low MCHC means hypochromic cells, carrying less hemoglobin per unit of cell volume. Limited iron availability is the most common explanation in adults, whether from low intake, poor absorption or ongoing blood loss. Inherited thalassemia traits, chronic inflammation that locks iron away from the marrow, and rarer issues such as copper deficiency can also produce the pattern.
Less than most people expect. Dehydration concentrates both hemoglobin and hematocrit at roughly the same rate, and because MCHC is the ratio between them, the calculated value usually stays fairly stable even when both inputs rise. Dehydration affects hemoglobin and hematocrit readings more than it affects MCHC.
MCH is the average mass of hemoglobin in a single red blood cell. MCHC is the concentration of hemoglobin per unit of cell volume. A small cell can have a low MCH while still being normally filled, which would leave MCHC in range. Reading both alongside MCV separates cells that are small from cells that are underfilled.
Yes. Red cell indices often shift before total hemoglobin falls below the reference range, so it is possible to see a hypochromic pattern while hemoglobin still reads normal. That is one reason iron storage markers such as ferritin are checked alongside the blood count, since they tend to change earlier than MCHC does.
It comes as part of any complete blood count, so it is checked whenever that panel is run. For tracking purposes, direction over repeat draws is far more informative than any single value, which is why FitScript members have 150+ biomarkers tested per year. Testing frequency for an individual result should be decided with a clinician.